Results 251 to 253 of about 22,100 (253)

Blocking ITGA5 potentiates the efficacy of anti‐PD‐1 therapy on glioblastoma by remodeling tumor‐associated macrophages

Cancer Communications, EarlyView.
Abstract Background Glioblastoma (GBM) is largely refractory to antibodies against programmed cell death 1 (anti‐PD‐1) therapy. Fully understanding the cellular heterogeneity and immune adaptations in response to anti‐PD‐1 therapy is necessary to design more effective immunotherapies for GBM.
Rongrong Zhao, Ziwen Pan, Jiawei Qiu, Boyan Li, Yanhua Qi, Zijie Gao, Wei Qiu, Weijie Tang, Xiaofan Guo, Lin Deng, Gang Li, Hao Xue   +11 more
wiley   +1 more source

Exceptionally long-lived nuclear RNAs. [PDF]

Science
Lawrence J, Hall L.
europepmc   +1 more source

RNA PolyA Tailing Assay to Qualitatively Analyze Circular RNA Manufacturing. [PDF]

Bio Protoc
Chuang ZS, Su CI, Wang HI, Yu CY.
europepmc   +1 more source